How long you can take ursodiol depends entirely on why you’re taking it. For some conditions, it’s a lifelong medication. For others, treatment lasts six months to two years. There is no single universal time limit, but each use case has well-established guidelines.
Lifelong Use for Primary Biliary Cholangitis
If you’re taking ursodiol for primary biliary cholangitis (PBC), the answer is indefinitely. Clinical guidelines are clear on this point: ursodiol at 13 to 15 mg per kilogram of body weight per day is the standard therapy for all PBC patients, regardless of how advanced the disease is, and it is meant to be taken for life. It has been the cornerstone of PBC treatment since its approval in 1994 and remains the first-line therapy for every patient with the condition.
Your doctor will evaluate your response after 12 months of treatment using blood tests that measure liver enzymes and bilirubin levels. Several validated scoring systems exist to determine whether the medication is working well enough. If your liver markers aren’t improving adequately, a second-line treatment may be added on top of ursodiol rather than replacing it. The goal over time is complete normalization of alkaline phosphatase and bilirubin, sometimes called a “deep biochemical response,” which is associated with the best long-term outcomes.
Because your weight can change over the years, your dose may need periodic adjustment to stay in the therapeutic range.
Six Months for Gallstone Prevention After Weight Loss Surgery
Rapid weight loss after bariatric surgery significantly increases the risk of developing gallstones. A six-month course of ursodiol, typically 500 mg per day in divided doses, is the standard preventive regimen. In clinical trials, this protocol was effective at preventing gallstone formation and allowed patients to avoid having their gallbladder removed at the same time as their weight loss procedure. Some studies have tested courses as short as two months, but six months is the most widely supported duration. Once the six months are over and your weight has stabilized, the medication is stopped.
One to Two Years for Gallstone Dissolution
When ursodiol is used to dissolve existing gallstones (rather than prevent them), treatment typically runs a year or longer. At higher doses taken for more than six months, roughly 37% of patients achieve complete dissolution. Even under the best circumstances, with small cholesterol stones in a functioning gallbladder, only about half of patients will be stone-free after six or more months of treatment.
The significant catch with this approach is what happens after you stop. Gallstone recurrence is common. In a 12-year follow-up study, 12.5% of patients had new stones within the first year of stopping ursodiol, and the cumulative recurrence rate climbed to 61% by the eleventh year. This high recurrence rate is one reason surgery remains the more common approach to gallstones.
Special Considerations for Children
In pediatric patients, particularly infants who have had surgery for biliary atresia, the treatment window is more carefully defined. Research shows that starting low-dose ursodiol within the first 12 months after surgery significantly improves jaundice and liver function, reducing the odds of elevated bilirubin by 80% to 86%. Benefits are more limited between 12 and 36 months. Beyond 36 months, continued use may actually be harmful, with one study finding it nearly doubled bile acid levels. This makes pediatric use distinctly different from adult PBC treatment, where long-term use is the norm.
Long-Term Safety Profile
Ursodiol is generally well tolerated, even over many years. Multiple large clinical trials and real-world studies confirm its high safety profile and good patient adherence over long-term treatment. The most common side effects are digestive: diarrhea, bloating, and occasionally weight gain. Some patients experience worsening itching early in treatment. True intolerance or allergy is rare.
That said, long-term pharmacovigilance data covering nearly two decades (2004 to 2023) has flagged some signals worth knowing about. Patients on ursodiol for extended periods should be aware of potential effects on oral health, including changes to the mouth’s lining and microenvironment. The data also identified possible associations with certain bile duct complications and reproductive system effects, though these have not been widely reported in controlled trials. These findings don’t change the overall favorable safety assessment, but they do reinforce the importance of ongoing monitoring.
Monitoring and Reasons to Stop
Regardless of why you’re taking ursodiol, your liver function needs regular monitoring. The standard schedule is monthly blood tests for the first three months, then every six months after that. These tests track liver enzymes and bilirubin to catch any deterioration early.
There are a few situations where ursodiol should be stopped or paused. If your liver function tests rise to clinically significant levels after previously being stable, your doctor will consider discontinuing it. If you develop symptoms of a gastrointestinal blockage, such as severe abdominal pain, vomiting, or inability to pass stool, the medication should be held until you’ve been evaluated. Ursodiol should not be used at all by anyone with complete bile duct obstruction or a known allergy to the drug.
Outside of these specific scenarios, there is no built-in expiration date on ursodiol therapy. For conditions like PBC, the medication is designed to be taken as long as it continues working, which for most patients means the rest of their lives. For gallstone-related uses, the duration is finite and defined by the clinical goal, whether that’s preventing stones during a high-risk window or dissolving ones that already exist.